N. Coles

N.
Anthony Coles was the founder of Yumanity, Inc., founded in 2014, where the title held was Executive Chairman from 2019 to 2020.
Dr. Coles was also the founder of Yumanity Therapeutics, Inc...
Current positions included Executive Chairman & Chief Executive Officer at Cerevel Therapeutics LLC since 2019, Independent Director at Regeneron Pharmaceuticals, Inc. since 2017, Director at Biotechnology Innovation Organization, Council on Foreign Relations, Inc., The United States Olympic Endowment, Yumanity, Inc., and Trustee at The Metropolitan Museum of Art, The Johns Hopkins University, and Boston Medical Center.
Also holds membership at Harvard Medical School and council membership at Smithsonians National Museum of Natural History.
Senior Advisor at The Vistria Group LP starting 2025.
Former roles include President, Chief Executive Officer & Director at NPS Pharmaceuticals, Inc. (2005–2008), President & Chief Executive Officer at Onyx Pharmaceuticals, Inc. (2013), Chairman & Chief Executive Officer at Trate Enterprises, LLC (2013–2014), Chairman & Chief Executive Officer at Cerevel Therapeutics, Inc., Chairman at CRISPR Therapeutics AG (2016–2017), Chairman at Cerevel Therapeutics Holdings, Inc. (2023–2024), Independent Director at Laboratory Corporation of America Holdings (2010–2012), Independent Director at McKesson Corp.
(2014–2021), Independent Director at Campus Crest Communities, Inc. (2010–2013), Director at Johns Hopkins Medicine, Inc. (2010–2011), Director at FoldRx Pharmaceuticals LLC, Seragon Pharmaceuticals, Inc., Yumanity Holdings LLC, and Bristol Myers Squibb Co. Senior Vice President-Strategy & Policy.
VP-Hypertension & Heart Failure Business Group at Merck & Co., Inc. (1992–1996).
Senior Vice President-Commercial Operations at Vertex Pharmaceuticals, Inc. (2002–2005).
Education includes a doctorate from Duke University, graduate studies at Harvard University, and undergraduate studies at The Johns Hopkins University.